Total Payments
$21,317
2024 Payments
$3,101
Companies
92
Transactions
1,014
Medicare Patients
7,004
Medicare Billing
$7.7M
Payment Breakdown by Category
Food & Beverage$20,699 (97.1%)
Education$617.94 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,699 | 991 | 97.1% |
| Education | $617.94 | 23 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,943 | 85 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,489 | 68 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,406 | 84 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,021 | 54 | $0 (2024) |
| Celgene Corporation | $984.81 | 39 | $0 (2024) |
| Genentech USA, Inc. | $901.37 | 47 | $0 (2024) |
| PFIZER INC. | $873.90 | 69 | $0 (2024) |
| Incyte Corporation | $755.82 | 24 | $0 (2024) |
| GENZYME CORPORATION | $704.40 | 30 | $0 (2024) |
| Amgen Inc. | $664.06 | 38 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,101 | 140 | AstraZeneca Pharmaceuticals LP ($258.76) |
| 2023 | $3,139 | 152 | E.R. Squibb & Sons, L.L.C. ($267.51) |
| 2022 | $2,745 | 121 | E.R. Squibb & Sons, L.L.C. ($428.94) |
| 2021 | $1,255 | 52 | Exelixis Inc. ($137.42) |
| 2020 | $915.98 | 39 | Incyte Corporation ($139.19) |
| 2019 | $4,301 | 202 | Merck Sharp & Dohme Corporation ($310.47) |
| 2018 | $3,878 | 188 | E.R. Squibb & Sons, L.L.C. ($555.63) |
| 2017 | $1,982 | 120 | Novartis Pharmaceuticals Corporation ($299.75) |
All Payment Transactions
1,014 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Cumberland Pharmaceuticals, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: ONCOLOGY | ||||||
| 12/27/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $22.92 | General |
| Category: Hematology | ||||||
| 12/13/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: HEMATOLOGY | ||||||
| 12/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.16 | General |
| 12/06/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: Oncology | ||||||
| 12/04/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Oncology | ||||||
| 11/27/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 11/21/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), REBLOZYL, WELIREG | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $16.93 | General |
| Category: Hematology/Oncology | ||||||
| 11/14/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: HORMONE THERAPY | ||||||
| 11/12/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.01 | General |
| 11/07/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug), Somatuline Depot | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Oncology | ||||||
| 11/05/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Oncology | ||||||
| 10/28/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 1,966 | 131,157 | $10.9M | $2.8M |
| 2022 | 48 | 2,351 | 178,326 | $13.0M | $3.3M |
| 2021 | 30 | 1,437 | 50,000 | $5.1M | $1.4M |
| 2020 | 14 | 1,250 | 2,476 | $545,098 | $189,923 |
Total Patients
7,004
Total Services
361,959
Medicare Billing
$7.7M
Procedure Codes
130
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9299 | Injection, nivolumab, 1 mg | Office | 2023 | 15 | 50,385 | $4.4M | $1.2M | 27.2% |
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 17 | 18,207 | $2.8M | $787,132 | 27.9% |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2023 | 13 | 6,502 | $812,750 | $218,652 | 26.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 291 | 1,514 | $416,350 | $193,812 | 46.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 23 | 5,580 | $351,540 | $103,308 | 29.4% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 35 | 4,100 | $282,900 | $67,782 | 24.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 79 | 665 | $626,040 | $60,158 | 9.6% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2023 | 14 | 6,861 | $178,386 | $42,086 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 313 | 456 | $104,880 | $38,378 | 36.6% |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 2023 | 11 | 396 | $216,612 | $32,721 | 15.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 336 | 1,691 | $20,292 | $14,197 | 70.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 71 | 260 | $48,360 | $11,565 | 23.9% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 20 | 27,030 | $81,090 | $10,680 | 13.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 14 | 152 | $42,104 | $7,594 | 18.0% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 29 | 161 | $66,010 | $7,306 | 11.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 44 | 44 | $21,560 | $6,908 | 32.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 74 | 621 | $105,570 | $6,246 | 5.9% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 55 | 477 | $85,860 | $5,299 | 6.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 40 | 238 | $42,840 | $4,902 | 11.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $11,550 | $4,866 | 42.1% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 27 | 316 | $58,140 | $4,653 | 8.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 26 | 206 | $61,800 | $4,187 | 6.8% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 45 | 171 | $30,780 | $1,538 | 5.0% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 31 | 64 | $25,600 | $1,423 | 5.6% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2023 | 23 | 76 | $5,624 | $1,306 | 23.2% |
About Dr. Jack Saux, MD
Dr. Jack Saux, MD is a Hematology & Oncology healthcare provider based in Covington, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528023843.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Saux, MD has received a total of $21,317 in payments from pharmaceutical and medical device companies, with $3,101 received in 2024. These payments were reported across 1,014 transactions from 92 companies. The most common payment nature is "Food and Beverage" ($20,699).
As a Medicare-enrolled provider, Saux has provided services to 7,004 Medicare beneficiaries, totaling 361,959 services with total Medicare billing of $7.7M. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Covington, LA
- Active Since 04/19/2006
- Last Updated 04/15/2019
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1528023843
Products in Payments
- KEYTRUDA (Biological) $1,378
- OPDIVO (Biological) $1,332
- Nerlynx (Drug) $504.38
- JEVTANA (Drug) $479.52
- KISQALI (Drug) $460.08
- Revlimid (Drug) $404.24
- JAKAFI (Drug) $400.97
- XTANDI (Drug) $388.51
- MONJUVI (Drug) $384.58
- CABOMETYX (Drug) $336.62
- IBRANCE (Drug) $331.72
- Cabometyx (Drug) $301.67
- LIBTAYO (Biological) $294.01
- LYNPARZA (Drug) $279.30
- ZEJULA (Drug) $275.51
- Onivyde (Drug) $266.21
- REBLOZYL (Biological) $263.50
- TECENTRIQ (Biological) $258.23
- Trodelvy (Drug) $233.23
- Perjeta (Biological) $230.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Covington
James Carinder, Do, DO
Hematology & Oncology — Payments: $25,360
Hematology & Oncology $25,360
Dr. Chris Theodossiou, Md, MD
Hematology & Oncology — Payments: $11,261
Hematology & Oncology $11,261
Mr. Anil Desai, Md, MD
Hematology & Oncology — Payments: $10,217
Hematology & Oncology $10,217
Chukwuma Ndibe, M.d, M.D
Hematology & Oncology — Payments: $8,827
Hematology & Oncology $8,827
Shanker Polsani, M.d.,, M.D.,
Hematology & Oncology — Payments: $8,134
Hematology & Oncology $8,134
Mrs. Victoria Afshani, Md, MD
Hematology & Oncology
Hematology & Oncology